Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$85.2K
383.00 shares
What this filing means
MESA NILDA plans to sell 383.00 shares of UNITED THERAPEUTICS CORP valued at approximately $85.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/13/2023ACC: 0001950047-23-004008
383.00
Shares to sell
$85.2K
Approx. market value
383.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/8/2022
383.00Total acquired383.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/8/2022 | Restricted Stock Not Applicable | 383.00 | — |
| Total | 383.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
383.00
Market value
$85.2K
9/13/2023
Total
Units
383.00
Value
$85.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/13/2023 | 383.00 | $85.2K | NASDAQ | Planned |
| Total | 383.00 | $85.2K | ||